Congenital dyserythropoietic anemia type I: First report from the Congenital Dyserythropoietic Anemia Registry of North America (CDAR).
Autor: | Niss O; Division of Hematology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA. Electronic address: Omar.niss@cchmc.org., Lorsbach RB; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA; Division of Pathology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA., Berger M; Division of Hematology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA., Chonat S; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA, USA., McLemore M; Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University School of Medicine, Atlanta, GA, USA., Buchbinder D; Department of Hematology, CHOC Children's Hospital, Orange, CA, USA., McCavit T; Cook Children's Hospital, Fort Worth, TX, USA., Shaffer LG; Dell Children's Medical Center, Austin, TX, USA., Simpson J; UF Health Pediatric Subspecialty Program in Pensacola, Pensacola, FL, USA., Schwartz JH; UF Health Pediatric Subspecialty Program in Pensacola, Pensacola, FL, USA., Meznarich J; Division of Hematology-Oncology, Department of Pediatrics, University of Utah, Salt Lake City, UT, USA; Primary Children's Hospital, Intermountain Healthcare, Salt Lake City, UT, USA., Emberesh M; Division of Hematology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA., Seu KG; Division of Hematology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA., Zhang W; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA; Laboratory of Genetics and Genomics, Division of Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA., Kalfa TA; Division of Hematology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA. Electronic address: theodosia.kalfa@cchmc.org. |
---|---|
Jazyk: | angličtina |
Zdroj: | Blood cells, molecules & diseases [Blood Cells Mol Dis] 2021 Mar; Vol. 87, pp. 102534. Date of Electronic Publication: 2020 Dec 24. |
DOI: | 10.1016/j.bcmd.2020.102534 |
Abstrakt: | Congenital dyserythropoietic anemias (CDAs) are characterized by ineffective erythropoiesis and distinctive erythroblast abnormalities; the diagnosis is often missed or delayed due to significant phenotypic heterogeneity. We established the CDA Registry of North America (CDAR) to study the natural history of CDA and create a biorepository to investigate the pathobiology of this heterogeneous disease. Seven of 47 patients enrolled so far in CDAR have CDA-I due to biallelic CDAN1 mutations. They all presented with perinatal anemia and required transfusions during infancy. Anemia spontaneously improved during infancy in three patients; two became transfusion-independent rapidly after starting interferon-α (Copyright © 2020 Elsevier Inc. All rights reserved.) |
Databáze: | MEDLINE |
Externí odkaz: |